{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:24:00Z","timestamp":1787261040723,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacl.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:46:48Z","timestamp":1786117608000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective analysis of serial lipoprotein(a) measurements in pediatric patients: Intraindividual variability and impact on risk stratification"],"prefix":"10.1016","author":[{"given":"Christian","family":"Menke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julya","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Illsinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele H.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieke","family":"Ringlstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anibh M.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.08.003_bib1","first-page":"934","article-title":"Ancestry, lipoprotein(a), and cardiovascular risk thresholds: JACC review topic of the week","volume":"80","author":"Tsimikas","year":"2022","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.08.003_bib2","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacl.2026.08.003_bib3","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1194\/jlr.R051904","article-title":"Lipoprotein (a): impact by ethnicity and environmental and medical conditions","volume":"57","author":"Enkhmaa","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacl.2026.08.003_bib4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.08.003_bib5","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2026.08.003_bib6","first-page":"470","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.08.003_bib7","first-page":"503","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"key":"10.1016\/j.jacl.2026.08.003_bib8","first-page":"716","article-title":"Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies","volume":"60","author":"Tsimikas","year":"2012","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.08.003_bib9","article-title":"The association between lipoprotein(a) levels and ischemic stroke in children: a case\u2013control study","volume":"71","author":"de Boer","year":"2024","journal-title":"Pediatr\u00a0Blood Cancer"},{"key":"10.1016\/j.jacl.2026.08.003_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2022.04.006","article-title":"Non-genetic influences on lipoprotein(a) concentrations","volume":"349","author":"Enkhmaa","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.003_bib11","first-page":"55","article-title":"Lipoprotein(a) and inflammation- pathophysiological links and clinical implications for cardiovascular disease","volume":"17","author":"Simantiris","year":"2023","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2026.08.003_bib12","first-page":"3683","article-title":"Treatment of thyroid dysfunction and serum lipids: a systematic review and meta-analysis","volume":"105","author":"Kotwal","year":"2020","journal-title":"J. Clin\u00a0Endocrinol\u00a0Metab"},{"key":"10.1016\/j.jacl.2026.08.003_bib13","first-page":"234","article-title":"Causes and consequences of lipoprotein(a) abnormalities in kidney disease","volume":"18","author":"Kronenberg","year":"2014","journal-title":"Clin\u00a0Exp\u00a0Nephrol"},{"key":"10.1016\/j.jacl.2026.08.003_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2022.04.004","article-title":"Lipoprotein(a): an underestimated inflammatory mastermind","volume":"349","author":"Dzobo","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.003_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.07.020","article-title":"Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease","volume":"308","author":"Jung","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.003_bib16","first-page":"779","article-title":"Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis","volume":"29","author":"de Boer","year":"2022","journal-title":"Eur\u00a0J\u00a0Prev\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.08.003_bib17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O\u2019Donoghue","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.08.003_bib18","first-page":"111","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur\u00a0Heart J"},{"key":"10.1016\/j.jacl.2026.08.003_bib19","first-page":"1998","article-title":"Equivalent impact of elevated lipoprotein(a) and familial hypercholesterolemia in patients with atherosclerotic cardiovascular disease","volume":"80","author":"Hedegaard","year":"2022","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.08.003_bib20","first-page":"324","article-title":"Lipoprotein(a) levels at birth and in early childhood: the COMPARE study","volume":"107","author":"Strandkj\u00e6r","year":"2022","journal-title":"J\u00a0Clin\u00a0Endocrinol\u00a0Metab"},{"key":"10.1016\/j.jacl.2026.08.003_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2022.03.004","article-title":"Lipoprotein(a) levels from childhood to adulthood: data in nearly 3,000 children who visited a pediatric lipid clinic","volume":"349","author":"de Boer","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.003_bib22","first-page":"290","article-title":"Effectiveness of cascade screening for elevated lipoprotein(a), an underdiagnosed family disorder","volume":"35","author":"Annink","year":"2024","journal-title":"Curr\u00a0Opin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2026.08.003_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2021.11.004","article-title":"Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a)","volume":"349","author":"Chakraborty","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.003_bib24","first-page":"1445","article-title":"pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members","volume":"12","author":"Zawacki","year":"2018","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"issue":"25","key":"10.1016\/j.jacl.2026.08.003_bib25","first-page":"00101","article-title":"Design and rationale of Lp(a)HORIZON trial: assessing the effect of lipoprotein(a) lowering with pelacarsen on major cardiovascular events in patients with CVD and elevated Lp(a)","volume":"S0002-8703","author":"Cho","year":"2025","journal-title":"Am\u00a0Heart J"},{"key":"10.1016\/j.jacl.2026.08.003_bib26","first-page":"e304","article-title":"Lipoprotein apheresis: utility, outcomes, and implementation in clinical practice: a scientific statement from the American Heart Association","volume":"44","author":"Gianos","year":"2024","journal-title":"Arterioscler\u00a0Thromb\u00a0Vasc\u00a0Biol"},{"key":"10.1016\/j.jacl.2026.08.003_bib27","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1080\/14656566.2022.2118522","article-title":"Pharmacotherapy for children with elevated levels of lipoprotein(a): future directions","volume":"23","author":"de Boer","year":"2022","journal-title":"Expert Opin\u00a0Pharmacother"},{"key":"10.1016\/j.jacl.2026.08.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2019.06.196","article-title":"Diagnosis of familial hypercholesterolemia in the clinical practice: performance of Dutch lipid clinic network score","volume":"287","author":"Bonaiti","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.003_bib29","first-page":"1855","article-title":"Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease","volume":"387","author":"O\u2019Donoghue","year":"2022","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"key":"10.1016\/j.jacl.2026.08.003_bib30","first-page":"e48","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler\u00a0Thromb\u00a0Vasc\u00a0Biol"},{"key":"10.1016\/j.jacl.2026.08.003_bib31","first-page":"177","article-title":"Lipoprotein(a) serum concentrations in children in relation to body mass index, age and sex","volume":"96","author":"St\u00fcrzebecher","year":"2024","journal-title":"Pediatr\u00a0Res"},{"key":"10.1016\/j.jacl.2026.08.003_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCULATIONAHA.122.060667","article-title":"Lipoprotein(a) in youth and prediction of major cardiovascular outcomes in adulthood","volume":"147","author":"Raitakari","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.08.003_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2022.07.009","article-title":"Long-term tracking and population characteristics of lipoprotein (a) in the Cardiovascular Risk in Young Finns Study","volume":"356","author":"Raitakari","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.003_bib34","first-page":"550","article-title":"Intraindividual variability in serial lipoprotein(a) concentrations among placebo-treated patients in the OCEAN(a)-DOSE trial","volume":"85","author":"Gaba","year":"2025","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.08.003_bib35","first-page":"397","article-title":"Lipoprotein(a) reduction with proprotein convertase subtilisin\/kexin type 9 inhibitors: a systematic review and meta-analysis","volume":"77","author":"Farmakis","year":"2021","journal-title":"J\u00a0Cardiovasc\u00a0Pharmacol"},{"key":"10.1016\/j.jacl.2026.08.003_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2022.04.021","article-title":"Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group","volume":"349","author":"Pederiva","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.003_bib37","article-title":"Genetics and pathophysiological mechanisms of lipoprotein(a)-associated cardiovascular risk","volume":"13","author":"Volgman","year":"2024","journal-title":"J\u00a0Am\u00a0Heart Assoc"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:28:45Z","timestamp":1787257725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426004794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"alternative-id":["S1933287426004794"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.08.003","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective analysis of serial lipoprotein(a) measurements in pediatric patients: Intraindividual variability and impact on risk stratification","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}